Table 2.
Predictive Value of Different Factors in Identifying Immunological and Virological Nonresponders
| |
At first follow-up (6 months) |
At second follow-up (12 months) |
||||||
|---|---|---|---|---|---|---|---|---|
| Parameter at baseline | INR | p value | VNR | p value | INR | p value | VNR | p value |
| Age group (years) | ||||||||
| <40 | 10 | 1 | 3 | 0.132 | 10 | 0.596 | 6 | 0.525 |
| ≥40 | 5 | 5 | 8 | 6 | ||||
| Gender | ||||||||
| Male | 9 | 0.555 | 6 | 1 | 9 | 0.098 | 8 | 1 |
| Female | 6 | 2 | 9 | 4 | ||||
| Clinical staging | ||||||||
| I | 8 | 0.844 | 4 | 0.673 | 12 | 0.173 | 3 | 0.846 |
| II | 3 | 1 | 3 | 5 | ||||
| III and IV | 4 | 3 | 3 | 4 | ||||
| CD4 counts (cells/μl) | ||||||||
| <50 | 0 | 0.181 | 2 | 0.427 | 2 | 0.022 | 3 | 0.1 |
| 50–199 | 12 | 6 | 9 | 9 | ||||
| ≥200 | 3 | 0 | 7 | 0 | ||||
| HIV viral load (copies/ml) | ||||||||
| <10,000 | 2 | 0.564 | 1 | 0.0126 | 3 | 0.6445 | 1 | 0.6001 |
| 10,000–100,000 | 4 | 5 | 4 | 1 | ||||
| ≥100,000 | 9 | 3 | 11 | 9 | ||||
INR, immunological nonresponders; VNR, virological nonresponders.